"Hematologic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that act on blood and blood-forming organs and those that affect the hemostatic system.
| Descriptor ID |
D006401
|
| MeSH Number(s) |
D27.505.954.502
|
| Concept/Terms |
Hematologic Agents- Hematologic Agents
- Agents, Hematologic
- Hematological Agents
- Agents, Hematological
|
Below are MeSH descriptors whose meaning is more general than "Hematologic Agents".
Below are MeSH descriptors whose meaning is more specific than "Hematologic Agents".
This graph shows the total number of publications written about "Hematologic Agents" by people in this website by year, and whether "Hematologic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hematologic Agents" by people in Profiles.
-
Sickle Cell Disease: A Review. JAMA. 2022 07 05; 328(1):57-68.
-
Management of the Jehovah's Witness in Obstetrics and Gynecology: A Comprehensive Medical, Ethical, and Legal Approach. Obstet Gynecol Surv. 2016 Aug; 71(8):488-500.
-
Gastrointestinal Bleeding during Continuous-Flow Left Ventricular Assist Device Support is Associated with Lower Rates of Cardiac Transplantation. ASAIO J. 2015 Nov-Dec; 61(6):635-9.
-
Off-label closure during CLOSURE study. J Invasive Cardiol. 2012 Nov; 24(11):608-11.
-
Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant. J Cardiothorac Surg. 2007 Jul 06; 2:32.
-
Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS. J Invasive Cardiol. 2003 Sep; 15(9):536-53.
-
Managing heart failure with immunomodulatory agents. Cardiol Clin. 2001 Nov; 19(4):617-25.